logo
Bringing dramatic drop in TB deaths, how TN set an example for rest of India with one-of-a-kind model

Bringing dramatic drop in TB deaths, how TN set an example for rest of India with one-of-a-kind model

The Printa day ago
While TB-related death simply refers to a death among a person with TB within 12 months of notification (diagnosis), early TB death refers to deaths that happen within two months, often within the first few weeks of the notification. It is estimated that around 70 percent of TB deaths in the state are early TB deaths.
An analysis by the agencies implementing the Tamil Nadu Kasanoi Erappila Thittam (TN-KET, which means TB death-free project) has shown that within six months of the launch of the initiative in April 2022, overall TB-related deaths have come down by nearly 10 percent while early TB fatalities reduced by nearly 20 percent.
Chennai: A first-of-its-kind statewide differentiated tuberculosis (TB) care initiative in Tamil Nadu has significantly brought down TB deaths in the state, prompting researchers to pitch it as a model that can be replicated across the country.
These results from TN-KET hold significance for India which continues to report the highest burden of TB and TB-related mortalities globally despite making significant strides in curbing the burden of the bacterial disease over the last several years.
India is considered a TB endemic country, a highly infectious disease caused by a bacteria called Bacillus Mycobacterium Tuberculosis, which is spread when people who are sick with TB expel the pathogen into the air, mostly by coughing.
Spearheaded by the Tamil Nadu State TB Cell and Indian Council of Medical Research-National Institute of Epidemiology (ICMR-NIE), the TN-KET initiative involves triaging (preliminary assessment) adults with TB at diagnosis, and those identified as severely ill based on specified indicators are prioritised immediately for referral, comprehensive assessment, and inpatient care.
'The key aim is to gauge or predict the patients who are likely to die due to the infectious disease while first identifying the disease in them and immediately offer them hospitalised care to treat the severe symptoms they have,' said ICMR-NIE director Dr Manoj Murhekar.
The initiative, also supported by the World Health Organisation (WHO) India and the ICMR National Institute for Research in TB (ICMR-NIRT), has been implemented in all 38 districts of Tamil Nadu, except for Chennai.
'This initiative has shown that it is possible to bring down TB-related deaths remarkably by following some scientifically designed tools and methods. Severe illness can be quickly identified through triaging and they can be promptly admitted after diagnosis,' Dr Hemant Deepak Shewade, a senior medical scientist with ICMR-NIE who is associated with the initiative, told ThePrint.
While the impact of the project in the first year has been analysed, the analysis of the second year (2023-24) is still underway but the early indications from routine monitoring of TN-KET suggest that it is even better than the previous results, Shewade said.
'We feel that scaling the model across India will be beneficial in bringing down the number of people dying every year due to the disease,' he added.
The senior scientist, however, cautioned that such an initiative could only bring down TB-related deaths by up to 30 percent, and measures like detecting all TB incidents, early detection, comorbidity management, universal health coverage, among others, were crucial to further reduce TB deaths in the country.
Dr Asha Frederick, Tamil Nadu's State TB Officer, said that district TB officers and Nodal physicians have played a key role in the implementation of the initiative. 'We recommend that these triage variables are captured elsewhere including other Indian states and high TB burden countries to guide patient management,' Dr Frederick said.
On the future plans for the TN-KET, the state has started identifying other severe comorbidities like uncontrolled Diabetes (requiring insulin) among people with TB. 'If this goes well, we plan to cover other severe comorbidities like severe addiction to alcohol and tobacco,' Frederick added.
According to the World TB report 2024 by the WHO, there were an estimated 28 lakh incident people with TB in 2023, 26 percent of global TB burden. Also, the country had an estimated 3.1 lakh TB deaths that year which was 29 percent of all TB mortalities globally.
Tamil Nadu is among the states with high TB burden in the country.
Also Read: Lancet report highlights gaps in immunisation—no routine vaccine for 14.4 lakh Indian kids in 2023
How the strategy works
As part of the project, health workers triage every new TB-diagnosed adult (all above 15 years) for very severe undernutrition, respiratory distress or poor physical condition on five variables—body mass index (BMI), pedal oedema (swelling of feet and ankles), respiratory rate, oxygen saturation, and ability to stand without support.
This is carried out as a health system initiative in routine operational settings by existing health workforce.
Whether or not a patient is severely ill is confirmed by entering the details into a software application TB SeWA (Severe TB Web Application). All those identified as severely ill are then prioritised for in-patient care by nodal physicians in nodal inpatient care facilities of the districts, using TN-KET case record form and in-patient care guides specifically developed for such patients.
A study published on the early implementation of the project and its feasibility underlined that 80-90 percent of severely ill patients (as per triage tool) are getting detected and admitted within one day of diagnosis.
The admission of severely ill patients (triage-positive) has improved over the years: 67 percent in 2022, 86 percent in 2023 and 91 percent in 2024. The median admission duration was five days in 2022 and this has improved to seven days in 2023 and 2024.
Over the years, the focus has been to ensure quality comprehensive assessment and inpatient care during the admission of the severely ill patients with focus on therapeutic nutrition for very severely undernourished patients as half of those eligible for admission have very severe undernutrition.
Between April 2022 and June 2023, as per details shared by ICMR-NIE scientists, 66,765 of 72,404 notified adults were triaged, and 7,950 were triage-positive (identified as severely sick due to TB).
Among these, 5,870 (or 74 percent) patents were referred and admitted. The analysis later showed 21 percent decline in early TB death rate and 11 percent reduction in overall TB death rate during treatment.
By improving the admission among triage-positive patients, there is scope to further reduce TB death rate, the researchers noted, adding that once the goal of 30 percent mortality rate reduction among notified TB patients using this strategy is achieved, they will consider adding follow up triaging for all patients at two months for further reduction in mortality rate.
As per the Sustainable Development Goals (SDG), India has to eliminate TB by 2030.
(Edited by Ajeet Tiwari)
Also Read: COVID-19 vaccines linked to cardiac-related deaths? Siddaramaiah, Biocon founder Shaw spar on X
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Obese or slim, over 71% Indians metabolically unhealthy, finds study
Obese or slim, over 71% Indians metabolically unhealthy, finds study

Time of India

time4 hours ago

  • Time of India

Obese or slim, over 71% Indians metabolically unhealthy, finds study

1 2 3 Nagpur: Over 71% Indians are metabolically unhealthy, even though many of them appear slim or of normal weight, finds a recently-published national-level study. The study, led by the Indian Council of Medical Research (ICMR), highlights how millions of Indians may appear slim on the outside but harbour silent threats like high blood sugar, bad cholesterol, and hidden body fat. This large-scale survey, part of the ongoing ICMR-INDIAB study initiated in 2012, was conducted across 31 states and Union Territories, covering a representative sample of 1,13,043 individuals aged 20 years and above from both urban and rural areas. One of the key co-authors of the study is Dr Prashant Joshi, executive director and CEO of AIIMS-Nagpur, who emphasised the urgency of these findings. "Our study shows that only about 26.6% of Indians are metabolically healthy. This means nearly three out of four people, even some who look thin, are at risk of serious diseases like diabetes and heart problems because of hidden metabolic issues," Dr Joshi told TOI. "This is one of the most recent and largest national studies on metabolic health. Our data shows that Indians are uniquely prone to having unhealthy fat inside the body — even if their weight is normal. So looking thin is not a guarantee of being healthy." "The most worrying part is that 71.6% are metabolically unhealthy in some way. This includes people who are overweight and those who look thin but are metabolically obese," said Dr Joshi. While the study covers the entire nation, Dr Joshi noted that cities like Nagpur are not immune to this hidden crisis. "We are increasingly seeing young people in Nagpur and Vidarbha with normal-weight but having high sugar, cholesterol or fatty liver," he said. Experts warn that depending only on body weight as a measure of health can be misleading. Dr Joshi urged people to undergo regular health check-ups. "This study should be a wake-up call. Thin does not always mean healthy," Dr Joshi said. # Four sub-groups identified in study Metabolically Obese Non-Obese (MONO) | 43.3% – Normal weight outside but unhealthy inside; high sugar, cholesterol, or blood pressure Metabolically Obese Obese (MOO) | 28.3% – Overweight or obese and also unhealthy inside; high sugar, bad cholesterol, or high blood pressure Metabolically Healthy Non-Obese (MHNO) | 26.6% – Normal weight and healthy inside; good sugar, cholesterol, and blood pressure Metabolically Healthy Obese (MHO) | 1.8% – Overweight or obese, but still healthy inside; normal sugar, cholesterol, and blood pressure for now

There's urgent need for awareness, immunisation against RSV in India: Doctors
There's urgent need for awareness, immunisation against RSV in India: Doctors

The Print

time9 hours ago

  • The Print

There's urgent need for awareness, immunisation against RSV in India: Doctors

According to Dr Khalatkar, the 2024 data is just the tip of the ice-berg: although it has been a notifiable infection for almost five decades, people do not test for it. Yet, RSV, often mistaken for a mild seasonal cold, is an under-discussed cause of lower respiratory tract infections in infants and children under five, he added. Bengaluru, Jul 8 (PTI) Just in 2024 alone, respiratory syncytial virus (RSV) claimed 2,360 lives of children in hospitals notified in Bengaluru, Kolkata and Mumbai, said Dr Vasant M Khalatkar, National President of the Indian Academy of Pediatrics (IAP) on Tuesday. 'Only when you see outbreaks — like the one that happened in Kolkata in January — do testing occur,' he pointed out. Dr Khalatkar was part of a three-member panel that participated in a roundtable discussion on the prevalence of RSV, organised by Dr Reddy's Laboratories Limited in Bengaluru on Tuesday. Dr Reddy's is partnering with Sanofi, a French biopharma company, to bring to India single-dose preventive immunisation developed to protect infants from RSV-related complications. Citing Indian Council for Medical Research (ICMR) and published studies, Dr Bhavesh Kotak, Head of Medical Affairs at Dr Reddy's, who was also part of the panel, said, 'RSV is the leading cause of respiratory illness in India, and when it deteriorates, it does so within three days of a cold-like symptom — from there on, the child develops serious complications like bronchiolitis and pneumonia.' He also quoted from a World Health Organization (WHO) study, which establishes that RSV is responsible for 63 per cent of acute respiratory infections in infants and young children worldwide. At the roundtable discussion, the doctors also stated that by the time babies turn two years old, they are infected by RSV at least once. They held that there is no biomarker to determine which child will become seriously ill and develop pneumonia and bronchiolitis. Representing Sanofi, Dr Cesar Mascarenas, Head of Medical International Region, said breast milk alone will not protect infants. 'The breastmilk is responsible for digestive tract-related immunity, while the placenta provides respiratory immunity, but this lasts about a month,' he said. 'We have long been working to close critical gaps in prevention by advancing science-driven solutions that align with evolving global recommendations, including those from the WHO,' added Mascarenas. Dr Kotak said India bears a significant share of the global RSV burden. 'Unlike high-income countries with advanced prevention care and early access to preventive solutions, India still faces challenges in timely diagnosis and protection. Increased awareness around the severity of RSV and enabled access to ground-breaking immunisation solutions will be critical in building a more equitable and effective national response to RSV,' he added. PTI JR SA This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

Need for awareness and immunization against Respiratory Syncytial Virus in India
Need for awareness and immunization against Respiratory Syncytial Virus in India

Hans India

time14 hours ago

  • Hans India

Need for awareness and immunization against Respiratory Syncytial Virus in India

Bengaluru: Medical experts in India are calling for urgent attention to Respiratory Syncytial Virus (RSV), a highly contagious but under-discussed cause of lower respiratory tract infections in infants and children under five. RSV, often mistaken for a mild seasonal cold, accounts for ~ 3.6 million hospitalizations and ~ 100,000 deaths in children under five each year globally. India, with the largest birth cohort of ~ 25 million newborns annually, contributes significantly to this burden. The impact is particularly severe during the country's monsoon and early winter months, when neonatal ICUs experience a surge in admissions. Alarmingly, even healthy, full-term infants across all socio-economic backgrounds often require oxygen or ventilator support due to RSV-related complications. Therefore, raising awareness among parents and healthcare professionals about available preventive measures is critical to reducing the disease's toll on young lives. Dr. Vasant M. Khalatkar, Current National President, Indian Academy of Pediatrics (IAP), said 'RSV remains a significant threat to infant health, and while hygiene measures like handwashing are essential, they're often not enough—especially for babies under one year. With the recent World Health Organization (WHO) recommendation for long-acting monoclonal antibodies (mAb) and India enabling access to these solutions, we now have vital tools to protect our youngest. Palivizumab has been available for high-risk infants, offering protection through monthly dosing during the RSV season. Now, with the arrival of Nirsevimab—a single-dose, long-acting antibody that provides season-long protection—we're seeing a major advancement. Administered shortly after birth or during routine follow-ups, these preventive options can greatly reduce RSV-related hospitalizations and shield infants from serious complications like bronchiolitis and pneumonia. Prevention, timely awareness, and parental engagement are critical to reducing RSV's impact across India.' Dr. Cesar Mascarenas, Head of Medical International Region, Sanofi, commented 'We have long been working to close critical gaps in prevention by advancing science-driven solutions that align with evolving global recommendations, including those from the WHO. Addressing RSV burden in India with advanced preventive care is the need of the hour. Strengthening awareness, improving access to protective interventions, and enabling timely immunization are essential steps in reducing the impact of RSV and safeguarding the health of future generations.' Dr. Bhavesh Kotak, Head, Medical Affairs, Dr. Reddy's, added 'India bears a significant share of the global RSV burden. Unlike high-income countries with advanced prevention care and early access to preventive solution, India still faces challenges in timely diagnosis and protection. Increased awareness around the severity of RSV and enabled access to ground-breaking immunization solutions will be critical in building a more equitable and effective national response to RSV.' In April 2025, Sanofi and Dr. Reddy's announced the expansion of their partnership to bring to India a novel, single-dose preventive immunization developed to protect infants from RSV-related complications. Caregivers or parents are advised to speak with their pediatricians / neonatologist for more details.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store